VIE/ALKB (VIE/ALKB)

Vienna Stock Exchange: VIE/ALKB · EUR

€32.6

+0.02 (+0.1%)· Recorded snapshot

Market cap	7.3B
Revenue (ttm)	913.4M
Net income (ttm)	181.4M
EPS (ttm)	€0.82
P/E (trailing)	40.0x
P/E (forward)	34.8x
Dividend	€0.21 (0.66%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 913.4M
Net income (ttm): 181.4M
EPS (ttm): €0.82
P/E (trailing): 40.0x
P/E (forward): 34.8x
Market cap: 7.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E34.8

P25 n/aP50 n/aP75 n/a

Trailing P/E40

P25 n/aP50 n/aP75 n/a

ROE21.2

P25 n/aP50 n/aP75 n/a

ROIC24.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ALKB indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

DKK

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	AT
Earnings date	2026-11-17
Employees	2,773
Employees change	-9
Employees growth	-0.32%
Enterprise value	EUR 7.1B
Exchange	Vienna Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1923
Industry	Biotechnology
Is primary listing	No
ISIN number	DK0061802139
Last earnings date	2026-08-20
Last refreshed	2026-10-29
Market cap	EUR 7.3B
Next earnings date	2026-11-17
Price	EUR 32.60
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	vie/ALKB
Website	https://www.alk.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	165.03x
Average P/E ratio (3Y)	42.57x
Average P/E ratio (5Y)	71.11x
Earnings yield	2.5%
EV/Earnings	39.39x
EV/EBIT	29.1x
EV/EBITDA	24.92x
EV/FCF	28.18x
EV/Sales	7.82x
FCF / EV yield	3.55%
FCF yield	3.46%
Forward P/E	34.83x
Graham number	8.67004
Graham upside	-73.4%
Lynch fair value	EUR 20.20
Lynch upside	-38.05%
P/(FCF - SBC) ratio	29.6x
P/(OCF - SBC) ratio	25.91x
P/B ratio	7.88x
P/E ratio	39.96x
P/FCF ratio	28.88x
P/OCF ratio	25.36x
P/S ratio	8.01x
Price / tangible book value	10.59x
Price/EBITDA ratio	26.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.87%
EBITDA margin	30.68%
Effective tax rate	26.58%
FCF margin	27.74%
Gross margin	68.18%
Operating margin	26.87%
Pretax margin	27.05%
Profit margin	19.86%
Profit per employee	EUR 65,407
Profitable quarters	20
Profitable years	6
Revenue per employee	EUR 329,397
ROA	12.75%
ROA (5Y)	7.16%
ROCE	22.22%
ROE	21.21%
ROE (5Y)	12.79%
ROIC	24.36%
ROIC (5Y)	12.46%
SBC / revenue	0.67%
Tax / revenue	7.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	36.38%
EPS growth (Q)	25%
EPS growth (QoQ)	-23.52%
EPS growth 10Y	11.69%
EPS growth 3Y	55.75%
EPS growth 5Y	89.49%
EPS growth quarters	13
EPS growth years	8
FCF growth	65.21%
FCF growth (Q)	-8.78%
FCF growth (QoQ)	-66.71%
FCF growth 5Y	58.24%
Gross profit growth	22.2%
Gross profit growth (Q)	20.1%
Gross profit growth 3Y	16.85%
Gross profit growth 5Y	16.73%
Net income growth	35.74%
Net income growth (Q)	28.9%
Net income growth (QoQ)	-22.43%
Net income growth 3Y	55.74%
Net income growth 5Y	89.84%
Net income growth quarters	13
Net income growth years	7
OCF growth	56.38%
OCF growth (Q)	-9.69%
OCF growth (QoQ)	-62.02%
OCF growth 10Y	16.77%
OCF growth 3Y	84.61%
OCF growth 5Y	43.23%
Operating income growth	35.03%
Operating income growth (Q)	18.67%
Operating income growth 3Y	51%
Operating income growth 5Y	59.28%
Revenue growth	16.52%
Revenue growth (Q)	17.55%
Revenue growth (QoQ)	1.36%
Revenue growth 10Y	8.66%
Revenue growth 3Y	13.42%
Revenue growth 5Y	13.34%
Revenue growth quarters	24
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -35.2M
Depreciation and amortization	EUR 34.8M
EBIT	EUR 245.4M
EBITDA	EUR 280.2M
EPS	EUR 0.82
Financing cash flow	EUR -73.4M
Free cash flow	EUR 253.5M
Free cash flow minus SBC	EUR 247.3M
Gross profit	EUR 622.8M
Income taxes	EUR 65.7M
Investing cash flow	EUR -51.2M
Net borrowing	EUR -21.7M
Net cash flow	EUR 164.1M
Net income	EUR 181.4M
Operating cash flow minus SBC	EUR 282.5M
Operating income	EUR 245.4M
Revenue	EUR 913.4M
Stock-based compensation	EUR 6.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	13.19
Book value per share	EUR 4.18
Debt / EBITDA	0.2
Debt / equity	0.06
Debt / FCF	0.22
Goodwill	EUR 61.1M
Interest coverage	183.5
Long-term assets	EUR 621.8M
Long-term liabilities	EUR 175.8M
Net cash (debt)	EUR 175.8M
Net cash / market cap	2.4%
Net debt / EBITDA	-0.63
Net debt / equity	-0.19
Net debt / FCF	-0.69
Piotroski F-Score	7
Property, plant and equipment	EUR 307.9M
Shareholders' equity	EUR 928.5M
Tangible book value	EUR 690.8M
Tangible book value per share	EUR 3.11
Total assets	EUR 1.3B
Total cash	EUR 232.2M
Total debt	EUR 56.4M
Total liabilities	EUR 372.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.76
Current assets	EUR 679M
Current liabilities	EUR 196.4M
Current ratio	3.46
Inventory turnover	1.22
Net working capital	EUR 258.3M
Quick ratio	2.09
Working capital	EUR 482.5M
Working capital turnover	0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.44%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-03-19
Dividend payment years	1
Dividend per share	EUR 0.21
Dividend yield	0.66%
Ex-dividend date	2026-03-17
Last dividend	EUR 0.21
Payout ratio	26.18%
Shareholder yield	1.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 30.84
1D price change	0.06%
1M price change	21.82%
1M total return	21.82%
1W price change	2.58%
1W total return	2.58%
20-day SMA	EUR 30.18
3M price change	8.31%
3M total return	8.31%
50-day SMA	EUR 28.47
52-week high	EUR 36.16
52-week high date	2026-06-15
52-week low	EUR 25.74
52-week low date	2026-09-15
6M price change	6.26%
6M total return	6.26%
All-time high	EUR 36.16
All-time high date	2026-06-12
All-time low	EUR 25.74
All-time low date	2026-09-15
Average true range (ATR)	EUR 0.57
Average volume	1.3
Change from 52-week high	-9.85%
Change from 52-week low	26.65%
Change from all-time high	-9.85%
Change from all-time low	26.65%
Change from open	-0.31%
Day's gap	0.37%
High price	EUR 32.70
Low price	EUR 32.32
Monthly RSI	0
Open price	EUR 32.70
Position in 52-week range	73.68%
Previous close	EUR 32.58
Price vs 150-day SMA	5.71%
Price vs 20-day SMA	8.01%
Price vs 50-day SMA	14.5%
Relative volume	20
RSI	71.21
Sharpe ratio	0.64
Sortino ratio	1.22
Weekly RSI	62.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132.1M
Shares change (QoQ)	1.43%
Shares change (YoY)	-0.44%
Shares held by institutions	15.87%

Deeper analysis on VIE/ALKB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ALKB report

Is a complete VIE/ALKB research report available?

No complete published report is available for vie/ALKB (VIE/ALKB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ALKB (VIE/ALKB)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ALKB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ALKB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ALKB

Frequently asked questions